Sign in

CIK 0001497253

  • Non-accelerated filer
  • Smaller reporting company

VivoSim Labs, INC.

Sign in to watch
Ticker
VIVS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
271488943
Phone
+1 858-224-1000
Business address
11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO, CA, 92121
Former names
ORGANOVO HOLDINGS, INC., REAL ESTATE RESTORATION & RENTAL, INC.
  1. 4 Shares withheld for taxes Chairman, CEO and President gave up 28,008 shares (to pay taxes)
  2. 4 Open-market sale Chief Financial Officer sold 15,000 shares at an average $7.50 ($112,521)
  3. 4 Open-market sale Chief Strategy Officer sold 20,000 shares at an average $7.55 ($150,997)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale EVP, Research & Dev & CTO sold 50,000 shares at $6.11 ($305,475)
  9. 4 Open-market sale Chief Strategy Officer sold 30,000 shares at $7.30 ($218,973)
  10. 4 Exercise or conversion Chief Financial Officer acquired 18,474 shares (option exercise)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Shares withheld for taxes Chief Financial Officer gave up 102,760 shares (to pay taxes)
  16. 4 Option exercise Director acquired 3,000 shares (option exercise)
  17. 5 Insider Annual Insider Trading Report
  18. 4 Exercise or conversion EVP of Commercial Operations acquired 50,000 shares (option exercise)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 12 of 16 · 306 filings